One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice
Michael Benatar MD, PhD, Lyle W. Ostrow MD, PhD, Joseph W Lewcock PhD, Frank Bennett PhD, Jeremy Shefner MD, PhD, Robert Bowser PhD, Paul Larkin PhD, Lucie Bruijn PhD, Joanne Wuu ScM
doi : 10.1002/ana.26860
Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis
Ikjae Lee MD, MSc, Hiroshi Mitsumoto MD, Seonjoo Lee PhD, Edward Kasarskis MD, PhD, Michael Rosenbaum MD, Pam Factor-Litvak PhD, Jeri W. Nieves PhD
doi : 10.1002/ana.26825
Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy
Mitsuharu Ueda MD, PhD, Yohei Misumi MD, PhD, Toshiya Nomura MD, PhD, Masayoshi Tasaki PhD, Shiori Yamakawa MD, Konen Obayashi MD, PhD, Taro Yamashita MD, PhD, Yukio Ando MD, PhD
doi : 10.1002/ana.26845
Improving Early Recognition of Treatment-Responsive Causes of Rapidly Progressive Dementia: The STAM3P Score
Nihal Satyadev MD, MPH, Philip W. Tipton MD, Yuka Martens PhD, S. Richard Dunham MD, Michael D. Geschwind MD, PhD, FANA, John C. Morris MD, FAAN, Matthew R. Brier MD, PhD, Neill R. Graff-Radford MD, Gregory S. Day MD, MSc, MSCI
doi : 10.1002/ana.26812
Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults
Xi Chen PhD, Tyler N. Toueg BS, Theresa M. Harrison PhD, Suzanne L. Baker PhD, William J. Jagust MD
doi : 10.1002/ana.26813
Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk
Heather E. Dark PhD, Clare Paterson PhD, Gulzar N. Daya MS, Zhongsheng Peng MD, PhD, Michael R. Duggan PhD, Murat Bilgel PhD, Yang An PhD, Abhay Moghekar MBBS, Christos Davatzikos PhD, Susan M. Resnick PhD, Kelsey Loupy PhD, Missy Simpson PhD, Julián Candia PhD, Thomas Mosley PhD, Josef Coresh PhD, Priya Palta PhD, Luigi Ferrucci MD, PhD, Allison Shapiro PhD, MPH, Stephen A. Williams MD, PhD, Keenan A. Walker PhD
doi : 10.1002/ana.26817
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
Lukai Zheng MD, MMed, Anna Rubinski PhD, Jannis Denecke MSc, Ying Luan MD, PhD, Ruben Smith MD, PhD, Olof Strandberg PhD, Erik Stomrud MD, PhD, Rik Ossenkoppele PhD, Diana Otero Svaldi PhD, Ixavier Alonzo Higgins PhD, Sergey Shcherbinin PhD, Michael J. Pontecorvo PhD, Oskar Hansson MD, PhD, Nicolai Franzmeier PhD, Michael Ewers PhD, for the Alzheimer's Disease Neuroimaging Initiative
doi : 10.1002/ana.26818
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease
Joshua D. Grill PhD, Charlene Flournoy MS, Shobha Dhadda PhD, Karin Ernstrom MS, Reisa Sperling MD, Doris Molina-Henry PhD, Kate Tranotti MBA, Russell Harris MBA, Michio Kanekiyo MS, Michelle Gee PhD, Michael Irizarry MD, Lynn Kramer MD, Paul Aisen PhD, Rema Raman PhD
doi : 10.1002/ana.26819
Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia
Lindsey A. Kuchenbecker BS, BA, Philip W. Tipton MD, Yuka Martens PhD, Matthew R. Brier MD, PhD, Nihal Satyadev MD, MPH, S. Richard Dunham MD, Evelyn B. Lazar MD, Maxwell V. Dacquel, Rachel L. Henson MS, Guojun Bu PhD, Michael D. Geschwind MD, PhD, FAAN, John C. Morris MD, FAAN, Suzanne E. Schindler MD, PhD, Elizabeth Herries BA, Neill R. Graff-Radford MD, FAAN, Gregory S. Day MD, MSc, MSCI, FAAN
doi : 10.1002/ana.26822
Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts
Nicole Saltiel BA, Yorghos Tripodis PhD, Talia Menzin MS, Aliyah Olaniyan MS, Zach Baucom PhD, Eukyung Yhang BS, Joseph N. Palmisano MPH, MA, Brett Martin MS, Madeline Uretsky MS, Evan Nair BS, Bobak Abdolmohammadi BA, Arsal Shah BS, Raymond Nicks MS, Christopher Nowinski PhD, Robert C. Cantu MD, Daniel H. Daneshvar MD, PhD, Brigid Dwyer MD, Douglas I. Katz MD, Robert A. Stern PhD, Victor E. Alvarez MD, Bertrand Huber MD, PhD, Patricia A. Boyle PhD, Julie A. Schneider MD, MS, Jesse Mez MD, MS, Ann C. McKee MD, Michael L. Alosco PhD, Thor D. Stein MD, PhD
doi : 10.1002/ana.26823
Deep Resequencing of the 1q22 Locus in Non-Lobar Intracerebral Hemorrhage
Livia Parodi PhD, Mary E. Comeau MA, Marios K. Georgakis MD, PhD, Ernst Mayerhofer MD, Jaeyoon Chung PhD, Guido J. Falcone MD, ScD, MPH, Rainer Malik PhD, Stacie L. Demel PhD, Bradford B. Worrall MD, MSc, Sebastian Koch MD, Fernando D. Testai MD, PhD, Steven J. Kittner MD, Jacob L. McCauley PhD, Christiana E. Hall MD, MS, Douglas J. Mayson MD, Mitchell S.V. Elkind MD, MS, Michael L. James MD, Daniel Woo MD, Jonathan Rosand MD, MSc, Carl D. Langefeld PhD, Christopher D. Anderson MD, MMSc
doi : 10.1002/ana.26814
Association of the Timing of Atrial Fibrillation Detection and Insular Involvement With the Risk of Embolic Events After Acute Ischemic Stroke
Keisuke Tokunaga MD, PhD, Kazunori Toyoda MD, PhD, Shunsuke Kimura MD, Kazuo Minematsu MD, PhD, Masahiro Yasaka MD, PhD, Yasushi Okada MD, PhD, Sohei Yoshimura MD, PhD, Masatoshi Koga MD; PhD, on behalf of the SAMURAI-NVAF and RELAXED investigators
doi : 10.1002/ana.26815
Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units
Babak B. Navi MD, MS, RPNI, Ivo Bach MD, Alexandra L. Czap MD, Mengxi Wang PhD, Jose-Miguel Yamal PhD, Asha P. Jacob MD, MPH, Stephanie A. Parker MHA, RN, Suja S. Rajan PhD, Saad Mir MD, Carla Sherman RN, Joshua Z. Willey MD, Jeffrey L. Saver MD, Michael O. Gonzalez MS, Noopur Singh MPH, William J. Jones MD, David Ornelas RN, Nicole R. Gonzales MD, Anne W. Alexandrov PhD, Andrei V. Alexandrov MD, May Nour MD, PhD, Ilana Spokoyny MD, Jason Mackey MD, Sarah Q. Collins BSN, RN, Kelly Silnes MS, Mathew E. Fink MD, Joey English MD, PhD, Nobl Barazangi MD, PhD, Patti L. Bratina RN, Jay Volpi MD, Chethan P. V. Rao MD, Laura Griffin DNP, David Persse MD, James C. Grotta MD … See fewer authors
doi : 10.1002/ana.26816
Endovascular Thrombectomy for a Progressive Stroke Patient With a High-Burden Carotid Free-Floating Thrombus
Zhikai Hou MD, PhD, Rongrong Cui MD, Ying Yu MD, Ning Ma MD
doi : 10.1002/ana.26820
De novo variants in KCNA3 cause developmental and epileptic encephalopathy
Maria Virginia Soldovieri PhD, Paolo Ambrosino PhD, Ilaria Mosca PhD, Ilenio Servettini PhD, Francesca Pietrunti MSc, Giorgio Belperio Msc, KCNA3 study group, Steffen Syrbe MD, Maurizio Taglialatela MD, PhD, Johannes R Lemke MD
doi : 10.1002/ana.26826
Determinants of Functional Outcome after Pediatric Hemispherotomy
Georgia Ramantani MD, PhD, Dorottya Cserpan PhD, Martin Tisdall MD, Willem M. Otte PhD, Georg Dorfmüller MD, PhD, J. Helen Cross MD, PhD, Monique van Schooneveld PhD, Pieter van Eijsden MD, Frauke Nees PhD, Gitta Reuner MD, PhD, Niklaus Krayenbühl MD, PhD, Josef Zentner MD, PhD, Christine Bulteau MD, PhD, Kees P. J. Braun MD, PhD
doi : 10.1002/ana.26830
Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson Disease: An Early Phase 18F-FP-CIT Positron Emission Tomography Study
Min Young Chun MD, PhD, Seok Jong Chung MD, PhD, Su Hong Kim MD, PhD, Chan Wook Park MD, Seong Ho Jeong MD, Hye Sun Lee PhD, Phil Hyu Lee MD, PhD, Young H. Sohn MD, PhD, Yong Jeong MD, PhD, Yun Joong Kim MD, PhD
doi : 10.1002/ana.26827
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3
Jennifer Faber MD, Moritz Berger PhD, Carlo Wilke MD, Jeannette Hubener-Schmid PhD, Tamara Schaprian MSc, Magda M. Santana PhD, Marcus Grobe-Einsler MD, Demet Onder MD, Berkan Koyak MD, Paola Giunti MD, Hector Garcia-Moreno MD, Cristina Gonzalez-Robles MD, Manuela Lima PhD, Mafalda Raposo PhD, Ana Rosa Vieira Melo MSc, LuÃÂs Pereira de Almeida PhD, Patrick Silva MSc, Maria M. Pinto MSc, Bart P. van de Warrenburg MD, PhD, Judith van Gaalen MD, Jeroen de Vries MD, Gulin Oz PhD, James M. Joers PhD, Matthis Synofzik MD, Ludger Schols MD, Olaf Riess MD, Jon Infante MD, Leire Manrique MD, Dagmar Timmann MD, Andreas Thieme MD, Heike Jacobi MD, Kathrin Reetz MD, Imis Dogan PhD, Chiadikaobi Onyike MD, Michal Povazan PhD, Jeremy Schmahmann MD, Eva-Maria Ratai PhD, Matthias Schmid PhD, Thomas Klockgether MD
doi : 10.1002/ana.26824
Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids: A Potentially Overlooked Diagnosis
Athanasios Tsibonakis MD, Aikaterini Theodorou MD, Penelope Korkolopoulou MD, Georgios Tsivgoulis MD
doi : 10.1002/ana.26821
A Letter Concerning a Role for Blood–Brain Barrier Dysfunction in Delirium following Noncardiac Surgery in Older Adults
Loic Le Guennec, Alexander Balcerac, Nicolas Weiss
doi : 10.1002/ana.26837
Reply to “A Letter Concerning a Role for Blood–Brain Barrier Dysfunction in Delirium following Noncardiac Surgery in Older Adults�
Michael J. Devinney MD, PhD, Miles Berger MD, PhD
doi : 10.1002/ana.26834
Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial
Debopam Samanta MD
doi : 10.1002/ana.26855
Reply to “Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial�
E. Martina Bebin MD, MPA
doi : 10.1002/ana.26857
Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions
Sohyeon Kim MD, Mi-Yeon Eun MD, Jae-Joon Lee MD, Hung Youl Seok MD
doi : 10.1002/ana.26859
Reply to “Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions�
Javier Villacieros-Ã�lvarez MD, Carmen Espejo PhD, Ã�lvaro Cobo-Calvo MD, PhD
doi : 10.1002/ana.26856
Correction to Lyden P, Pryor KE, Coffey CS, et al. Final results of the RHAPSODY trial: a multi-center, phase 2 trial using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a recombinant variant of human activated protein C, in combination with tissue plasminogen activator, mechanical thrombectomy or both in moderate to severe acute ischemic stroke. Ann Neurol 2019;85:125–136.
doi : 10.1002/ana.26841
